Cognitive Capital: The Psychedelic Revolution in Corporate Culture: Micro-Dosing, Neuroplasticity, and the Biochemical Optimization of Elite Executive Performance

The traditional corporate landscape has long relied on caffeine, extreme scheduling, and prescription stimulants to extract maximum productivity from top-tier executives. However, technology venture capitalists and Wall Street hedge fund managers have quietly pivoted toward a highly controversial, radically different biochemical strategy. They are aggressively weaponizing heavily restricted hallucinogens to artificially manufacture creativity and lateral thinking.

This exploration deconstruc...